TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/21/2023
Back to search
Official data from USPTO
PHARMASEQ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
09/21/2023
Classification
Registered
Trademark type
Word
Nice classes
42
Filing date
08/27/1998
Registration date
04/17/2001
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/21/2021
Last transaction
09/21/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
1999-01-00
First use in commerce
1999-01-00
Drawing code
1
Owner type
03
Owner location
Chicago, IL
Examiner
SAITO, KIM
Law office
L90
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
P-CHIP IP HOLDINGS INC.
PharmaSeq, Inc.
PharmaSeq, Inc.
Representatives
Michael A. Geller DLA Piper LLP (US)
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development of diagnostic assays in vitro and screens for pharmaceutical drug discovery for others; design for others in the field of DNA-based assaysDNA sequencing protocolsimmunoassay and methods for drug discovery; scientific researchdevelopment of methods to tag macroscopic objectsmolecules or groups of molecules with microtranspondersto detect such tagged objects or molecules; biochemical and genetic research for the development of pharmaceuticals or diagnostic methods
Publications
History of USPTO decisions and trademark events.
38 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/21/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/21/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/21/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/21/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/22/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/21/2021
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
07/21/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/21/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/21/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
04/12/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/17/2020
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/30/2010
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/30/2010
E89R
TEAS SECTION 8 & 9 RECEIVED
04/28/2010
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/28/2010
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/28/2010
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/22/2007
PLGL
ASSIGNED TO PARALEGAL
05/15/2007
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/18/2007
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/18/2007
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
04/17/2007
E815
TEAS SECTION 8 & 15 RECEIVED
04/17/2007
CFIT
CASE FILE IN TICRS
11/15/2006
R.PR
REGISTERED-PRINCIPAL REGISTER
04/17/2001
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/16/2001
DOCK
ASSIGNED TO EXAMINER
01/12/2001
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/08/2001
EX1G
SOU EXTENSION 1 GRANTED
01/08/2001
IUAF
USE AMENDMENT FILED
10/18/2000
EXT1
SOU EXTENSION 1 FILED
10/18/2000
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
04/25/2000
PUBO
PUBLISHED FOR OPPOSITION
02/01/2000
NPUB
NOTICE OF PUBLICATION
12/30/1999
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/05/1999
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/07/1999
CNRT
NON-FINAL ACTION MAILED
03/29/1999
DOCK
ASSIGNED TO EXAMINER
03/02/1999
Continuous trademark protection
Get notified about every new filing that threatens PHARMASEQ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.